INS and diabetes mellitus: These findings indicate that exposure to a single pro-diabetes drug can cause organ/tissue degeneration characterized by impairments in insulin signaling and energy metabolism, with attendant increased oxidative stress, mitochondrial dysfunction, and cell death.